Related Experiment Video
Updated: Jul 26, 2026

Using a Laminating Technique to Perform Confocal Microscopy of the Human Sclera
Published on: May 6, 2016
Localized scleroderma
1University of California, San Francisco 94108, USA.
Abstract:
Localized scleroderma can be divided into three main subtypes: morphea, linear scleroderma, and generalized morphea. Plaque morphea usually has a good prognosis. Variants of morphea, including guttate morphea and atrophoderma of Pasini and Pierini, are seen. Linear scleroderma, whether involving an extremity or the face, is often associated with serological abnormalities. Cosmetic and functional prognosis may be poor. Therapy is usually ineffective. Generalized morphea may be difficult to differentiate from systemic scleroderma. However, progression to systemic scleroderma is uncommon.
Insights
Localized scleroderma presents in three subtypes: morphea, linear, and generalized forms. While plaque morphea has a good prognosis, linear and generalized types may have poorer outcomes and limited treatment effectiveness.
Area of Science:
- Dermatology
- Rheumatology
- Autoimmune Diseases
Background:
- Localized scleroderma encompasses morphea, linear scleroderma, and generalized morphea.
- Plaque morphea generally presents with a favorable prognosis.
- Variants like guttate morphea and atrophoderma of Pasini and Pierini are recognized.
Purpose of the Study:
- To outline the classification and clinical characteristics of localized scleroderma subtypes.
- To discuss the prognostic factors and therapeutic challenges associated with each subtype.
- To differentiate generalized morphea from systemic scleroderma.
Main Methods:
- Review of existing literature on localized scleroderma classification and subtypes.
- Analysis of clinical presentations, serological associations, and prognoses.
- Comparison of generalized morphea with systemic scleroderma.
Main Results:
- Morphea, linear scleroderma, and generalized morphea are distinct subtypes.
- Linear scleroderma, particularly affecting extremities or face, shows serological abnormalities and poor cosmetic/functional prognosis.
- Generalized morphea is challenging to distinguish from systemic scleroderma, but progression is rare.
Conclusions:
- Localized scleroderma subtypes exhibit varied prognoses and clinical features.
- Effective therapies for localized scleroderma remain limited.
- Distinguishing generalized morphea from systemic scleroderma is crucial, with uncommon progression to systemic disease.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Reticular Dermis
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Atherosclerosis I: Introduction
Cirrhosis I: Introduction

